Combination of CCR4 Inhibitor C‐021 or TGFβR1 Inhibitor Galunisertib With Anti‐PD‐L1 Hinders SOX12‐Mediated HCC Progression and Metastasis. The gene discussed is TGFBR1; the disease is hepatocellular carcinoma.